The chips are down
Article Abstract:
Santa Clara-based Affymetrix and San Diego-based Illumina are fighting for the biggest growth opportunity in the biotechnology field, which is worth US$500 million. These two companies are planning to exploit another nascent gene-chip market in the diagnosis of specific diseases, an annual market that could one day top $1 billion.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
Copycat consolidation
Article Abstract:
Generic drugmakers are using various strategies, including mergers for surviving as more blockbuster drugs are coming off patent.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: The capacity of visual working memory for features and conjunctions. Neutral activity predicts individual differences in visual working memory capacity
- Abstracts: Eastern Pacific cooling and Atlantic overturning circulation during the last deglaciation. Cool stratification
- Abstracts: Cortical substrates for exploratory decisions in humans. The coast in colour. Temporal difference models describe higher-order learning in humans:
- Abstracts: Hwang scandal hit Korean biotech hard. Too much, too soon. An auspicious victory
- Abstracts: Evidence for magmatic evolution and diversity on Mars from infrared observations. On Earth, as it is on Mars?